A detailed history of Gamma Investing LLC transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Gamma Investing LLC holds 10,693 shares of MREO stock, worth $45,552. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,693
Previous 6,765 58.06%
Holding current value
$45,552
Previous $24.4 Million 80.45%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$3.45 - $4.87 $13,551 - $19,129
3,928 Added 58.06%
10,693 $43.9 Million
Q2 2024

Jul 02, 2024

BUY
$2.58 - $4.25 $2,007 - $3,306
778 Added 12.99%
6,765 $24.4 Million
Q1 2024

Apr 05, 2024

BUY
$2.3 - $4.05 $3,162 - $5,568
1,375 Added 29.81%
5,987 $19.8 Million
Q4 2023

Feb 01, 2024

BUY
$1.19 - $2.42 $5,488 - $11,161
4,612 New
4,612 $17.5 Million

Others Institutions Holding MREO

About Mereo Biopharma Group plc


  • Ticker MREO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,986,000
  • Market Cap $532M
  • Description
  • Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...
More about MREO
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.